COVID image

COHG-SA

Significant Variant

NamePaperDescription of ComparisonGeneGene IDRSIDAssociationDisease StatusMAF
(from paper)		Statistical Odds RatioStatistical P-value
Cantalupo_rs12639314 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Hospitalised cases vs controls CCR5 rs12639314 rs12639314 positive Severe Not available 1.23 7.10e-09
Cantalupo_rs34418657 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Hospitalised cases with heterozygous SNP vs control CCR5 ENSG00000160791 rs34418657 positive Severe Not available Not available 2.70e-02
Cantalupo_rs35951367 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Hospitalised cases vs controls CCR5 ENSG00000160791 rs35951367 positive Severe Not available 1.32 3.20e-19
Cantalupo_rs35951367 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Hospitalised cases vs controls replication study 1 CCR5 ENSG00000160791 rs35951367 positive Severe Not available 1.41 3.79e-06
Cantalupo_rs35951367 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Hospitalised cases vs control replication study 2 CCR5 ENSG00000160791 rs35951367 positive Severe Not available 1.307 4.30e-02
Cantalupo_rs9845542 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Hospitalised cases vs controls CCR5 ENSG00000160791 rs9845542 positive Severe Not available 1.33 4.20e-20
Chen_rs10786398 Host genetic effects in Pneumonia COVID-19 HGI severity vs contr R3HCC1L ENSG00000166024 rs10786398 Positive Severe Not available 1.19 3.72e-02
COVID-19 HGI_10490770 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls LZTFL1, CXCR6, LOC107986083 ENSG00000163818 rs10490770 Positive Severe 0.081 1.649 1.44e-73
COVID-19 HGI_10490771 Mapping the human genetic architecture of COVID-19 Critical vs Controls LZTFL1, CXCR6, LOC107986083 ENSG00000163818 rs10490770 Positive Critical 0.075 1.885 2.20e-61
COVID-19 HGI_rs10774671 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls OAS1, OAS2, OAS3 ENSG00000089127 rs10774671 Positive Severe 0.664 1.107 6.14e-10
COVID-19 HGI_rs10774671 Mapping the human genetic architecture of COVID-19 Critical vs Controls OAS1, OAS2, OAS3 ENSG00000089127 rs10774671 Positive Critical 0.652 1.2 4.08e-13
COVID-19 HGI_rs11918389 Mapping the human genetic architecture of COVID-19 Susceptibility vs Control RPL24, CEP97, NXPE3, ZBTB11 ENSG00000114391 rs11918389 Negative Mild 0.354 0.941 3.46e-15
COVID-19 HGI_rs13050728 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls IFNAR2 ENSG00000159110 rs13050728 Negative Severe 0.651 0.861 2.72e-20
COVID-19 HGI_rs13050728 Mapping the human genetic architecture of COVID-19 Critical vs Controls IFNAR2 ENSG00000159110 rs13050728 Negative Critical 0.652 0.819 1.05e-16
COVID-19 HGI_rs1819040 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls KANSL1, ARHGAP27, PLEKHM1, LINC02210-CRHR1, CRHR1, SPPL2C, MAPT, STH, LRRC37A, ARL17B, LRRC37A2, ARL17A, NSF, WNT3 ENSG00000120071 rs1819040 Negative Severe 0.186 0.879 1.83e-10
COVID-19 HGI_rs1886814 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls FOXP4 ENSG00000234753 rs1886814 Positive Severe 0.042 1.262 1.11e-09
COVID-19 HGI_rs2109069 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls DPP9 ENSG00000142002 rs2109069 Positive Severe 0.312 1.154 2.76e-17
COVID-19 HGI_rs2109069 Mapping the human genetic architecture of COVID-19 Critical vs Controls DPP9 ENSG00000142002 rs2109069 Positive Critical 0.316 1.26 9.68e-22
COVID-19 HGI_rs2271616 Mapping the human genetic architecture of COVID-19 Susceptibility vs Control SLC6A20, CCR3, LOC107986082 ENSG00000163817 rs2271616 Positive Mild 0.118 1.155 1.79e-34
COVID-19 HGI_rs4801778 Mapping the human genetic architecture of COVID-19 Susceptibility vs Control PLEKHA4, PPP1R15A, TULP2, NUCB1, HSD17B14 ENSG00000105559 rs4801778 Negative Susceptibility 0.18 0.946 1.18e-08
COVID-19 HGI_rs529565 Mapping the human genetic architecture of COVID-19 Susceptibility vs Control ABO ENSG00000175164 rs529565 Negative Susceptibility 0.651 0.905 1.45e-39
COVID-19 HGI_rs72711165 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls TMEM65 ENSG00000164983 rs72711165 Positive Severe 0.013 1.37 2.13e-09
COVID-19 HGI_rs74956615 Mapping the human genetic architecture of COVID-19 Hospitalised vs Controls RAVER1, FDX2, ICAM1, ICAM4, ICAM5, ZGLP1, ICAM3, TYK2 ENSG00000161847 rs74956615 Positive Severe 0.048 1.266 5.50e-10
COVID-19 HGI_rs74956615 Mapping the human genetic architecture of COVID-19 Critical vs Controls RAVER1, FDX2, ICAM1, ICAM4, ICAM5, ZGLP1, ICAM3, TYK2 ENSG00000161847 rs74956615 Positive Critical 0.048 1.434 9.71e-12
COVID-19 HGI_rs77534576 Mapping the human genetic architecture of COVID-19 Critical vs Controls KAT7, TAC4, DLX3, FLJ45513 ENSG00000136504 rs77534576 Positive Critical 0.033 1.446 4.37e-09
David_rs12329760 A common TMPRSS2 variant has a protective effect against severe COVID-19 COVID-19 severe EUR cases vs control SARS-CoV-2 negative TMPRSS2 ENSG00000184012 rs12329760 negative Critical Not available 0.87 1.00e-02
David_rs12329760 A common TMPRSS2 variant has a protective effect against severe COVID-19 Trans-ancestry metanalysis severe vs control SARS-CoV2 negative TMPRSS2 ENSG00000184012 rs12329760 negative Critical Not available 0.84 5.80e-04
David_rs12329760 A common TMPRSS2 variant has a protective effect against severe COVID-19 COVID HGI validation hospitalisation vs control general population TMPRSS2 ENSG00000184012 rs12329760 negative Severe Not available 0.95 4.72e-06
Ellinghaus_rs11385942 Genomewide association study of severe Covid-19 with respiratory failure Meta severity vs control LZTFL1,FYCO1,CXCR6,CCR2,CCR3,CCR9,SLC6A20,XCR1 ENSG00000163818 rs11385942 Positive Severe Not available 1.77 1.15e-10
Ellinghaus_rs657152 Genomewide association study of severe Covid-19 with respiratory failure Meta severity vs control ABO ENSG00000175164 rs657152 Positive Severe Not available 1.32 4.95e-08
Fadista_rs35705950 Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity >60 hospitalised vs pop contrl MUC5B ENSG00000117983 rs35705950 Negative Severe Not available 0.86 2.99e-02
Fallerini_c.901T>C Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Young male severe COVID-19 cases TLR7 ENSG00000196664 - positive Severe Not available Not available Not available
Fallerini_rs147244662 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Young male severe COVID-19 cases TLR7 ENSG00000196664 rs147244662 positive Severe Not available Not available Not available
Fallerini_rs149314023 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Young male severe COVID-19 cases TLR7 ENSG00000196664 rs149314023 positive Severe Not available Not available Not available
Fallerini_rs189681811 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Young male severe COVID-19 cases TLR7 ENSG00000196664 rs189681811 positive Critical Not available Not available Not available
Fallerini_rs200146658 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Young male severe COVID-19 cases TLR7 ENSG00000196664 rs200146658 positive Severe Not available Not available Not available
Fallerini_rs5743781 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Young male severe COVID-19 cases TLR7 ENSG00000196664 rs5743781 positive Severe Not available Not available Not available
Freitas_rs2282679 Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID?19 disease severity Severity GC ENSG00000145321 rs2282679 Severity Severe Not available Not available 2.00e-03
Gomez_rs4646994 Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Homozygous deletion vs severe COVID cases ACE ENSG00000159640 rs4646994 positive Severe Not available Not available 4.90e-02
Gomez_rs4646994 Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Homozygous deletion vs severe COVID males vs females ACE ENSG00000159640 rs4646994 positive Severe Not available Not available 4.30e-02
Horowitz_2_rs11919389 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 severe vs not hospitalised RPL24, CEP97, NXPE3, ZBTB11 ENSG00000114391 rs11919389 positive Severe Not available Not available 2.90e-02
Horowitz_2_rs143334143 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 positive vs COVID-19 negative or unknown CCHCR1 ENSG00000204536 rs143334143 positive Susceptibility 7.0 1.06 2.00e-04
Horowitz_2_rs143334143 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 severe vs not hospitalised CCHCR1 ENSG00000204536 rs143334143 positive Severe Not available 1.14 3.06e-02
Horowitz_2_rs1886814 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 severe vs not hospitalised FOXP4 ENSG00000234753 rs1886814 positive Severe Not available Not available 1.80e-02
Horowitz_2_rs190509934 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 positive vs COVID-19 negative or unknown ACE2 ENSG00000130234 rs190509934 negative Susceptibility 0.3 0.6 4.50e-13
Horowitz_2_rs2109069 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease Hospitalised COVID-19 vs negative/unknown DPP9 ENSG00000142002 rs2109069 positive Susceptibility 31.0 1.1 3.00e-07
Horowitz_2_rs2109069 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 hospitalised vs not hospitalised DPP9 ENSG00000142002 rs2109069 positive Severe Not available 1.08 5.66e-04
Horowitz_2_rs2236757 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease Hospitalised COVID-19 vs negative/unknown IFNAR2 ENSG00000159110 rs2236757 positive Susceptibility 29.0 1.08 7.00e-05
Horowitz_2_rs2236757 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 hospitalised vs not hospitalised IFNAR2 ENSG00000159110 rs2236757 positive Severe Not available 1.08 1.76e-03
Horowitz_2_rs2531743 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 positive vs COVID-19 negative SLC6A20 ENSG00000163817 rs2531743 positive Susceptibility 42.0 0.94 3.00e-12
Horowitz_2_rs73064425 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease severe COVID-19 vs COVID-19negative or unknown LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 ENSG00000163818 rs73064425 positive Susceptibility 7.0 1.58 2.00e-18
Horowitz_2_rs73064425 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 severe vs not hospitalised LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 ENSG00000163818 rs73064425 positive Severe Not available 1.59 4.28e-15
Horowitz_2_rs879055593 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease COVID-19 positive vs COVID-19 negative or unknown ABO ENSG00000175164 rs879055593/9411378 positive Susceptibility 24.0 1.1 7.00e-34
Horowitz_rs12461764 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data FPR1, HAS1 ENSG00000171051 rs12461764 Positive Severe 0.35 1.18 1.00e-08
Horowitz_rs143334143 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data MHC (CCHCR1) ENSG00000204536 rs143334143 Positive Severe 0.07 1.36 6.00e-04
Horowitz_rs2109069 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data DPP9 ENSG00000142002 rs2109069 Positive Severe 0.31 1.06 1.00e-04
Horowitz_rs2236757 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data IFNAR2 ENSG00000159110 rs2236757 Negative Severe 0.29 1.13 2.00e-04
Horowitz_rs2531743 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data SLC6A20, LOC107986082,LZTFL1, SACML1, CCR9, FYCO1, XCR1, CCR3, CCR1 ENSG00000163817 rs2531743 Positive Susceptibility 0.42 1.06 9.00e-04
Horowitz_rs4782327 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data ACSF3 ENSG00000176715 rs4782327 Positive Severe 0.22 1.17 8.00e-09
Horowitz_rs73064425 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data LZTFL1, CCR9, SLC6A20, FYCO1, CXCR6, XCR1, CCR1, CCR3 ENSG00000163818 rs73064425 Positive Severe 0.07 1.42 7.00e-11
Horowitz_rs79833209 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data LOC105377700, CCNG1, NUDCD2, HMMR ENSG00000113328 rs79833209 Positive Severe 0.02 1.54 2.00e-08
Horowitz_rs9411378 Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease Meta analysis, External data ABO ENSG00000175164 rs9411378 Positive Susceptibility 0.23 1.12 6.00e-10
Hubacek_rs4646994 ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors I/I homozygous symptomatic COVID cases vs asymptomatic ACE ENSG00000159640 rs4646994 positive Mild Not available 1.78 2.00e-03
Hu_rs117217714 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals WSB1, LGALS9, KSR1, NOS2, LYRM9 ENSG00000109046 rs117217714 Positive Severe 0.013 6.255 3.30e-05
Hu_rs117928001 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals STXBP5, STXBP5-AS1 ENSG00000233452 rs117928001 Positive Severe 0.049 2.749 1.10e-05
Hu_rs13227460 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals TOMM7, STEAP1B, IL-6, ENSG00000196683 rs13227460 Positive Severe 0.278 1.3 2.60e-02
Hu_rs2176724 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals DNAH7, SLC39A10 ENSG00000118997 rs2176724 Positive Severe 0.138 1.484 6.10e-03
Hu_rs2301762 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals CLUAP1 ENSG00000103351 rs2301762 Positive Severe 0.055 2.541 2.00e-05
Hu_rs4735444 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals CPQ, LOC101927066 ENSG00000104324 rs4735444 Positive Severe 0.201 1.784 5.80e-06
Hu_rs531453964 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals CPQ, LOC101927066 ENSG00000104324 rs531453964 Positive Severe 0.185 1.849 3.20e-06
Hu_rs71040457 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals DES, SPEG ENSG00000175084 rs71040457 Positive Severe 0.355 1.331 7.70e-03
Hu_rs9804218 Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data COVID-19 positive individuals PCDH15 ENSG00000150275 rs9804218 Positive Severe 0.357 1.373 3.30e-03
Jelinek_rs10901251 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 Jelinek_rs10901251 negative Critical Not available Not available 3.70e-02
Jelinek_rs13291798 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs13291798 negative Critical Not available Not available 1.30e-02
Jelinek_rs199969472 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs199969472 negative Critical Not available Not available 2.00e-03
Jelinek_rs34039247 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs34039247 negative Critical Not available Not available 4.00e-03
Jelinek_rs34266669 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs34266669 negative Critical Not available Not available 2.00e-03
Jelinek_rs76700116 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs76700116 negative Critical Not available Not available 2.00e-03
Jelinek_rs7849280 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs7849280 negative Critical Not available Not available 2.00e-03
Jelinek_rs9411475 Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation Critical vs non-critical (O blood group) ABO ENSG00000175164 rs9411475 negative Critical Not available Not available 9.00e-03
Kuo_rs429358 APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort APOE e4e4 vs APOE e3e3 ApoE ENSG00000130203 rs429358 Positive Severe 0.03 2.31 1.19e-06
Kuo_rs7412 APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort APOE e4e4 vs APOE e3e3 APOE ENSG00000130203 rs7412 Positive Severe 0.03 2.31 1.19e-06
Latini_rs114363287 COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells COVID-19 positive vs GnomAD TMPRSS2 ENSG00000184012 rs114363287 Positive Severe 0.004 Not available 1.63e-02
Latini_rs12329760 COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells COVID-19 positive vs GnomAD TMPRSS2 ENSG00000184012 rs12329760 Negative Susceptibility 0.17 Not available 2.28e-02
Latini_rs1236237792 COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells COVID-19 positive vs GnomAD Furin ENSG00000140564 rs1236237792 Positive Severe 0.004 Not available Not available
Latini_rs75603675 COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells COVID-19 positive vs GnomAD TMPRSS2 ENSG00000184012 rs75603675 Negative Susceptibility 0.36 Not available 4.46e-02
Latini_rs769208985 COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells COVID-19 positive vs GnomAD Furin ENSG00000140564 rs769208985 Positive Severe 0.004 Not available 4.70e-03
Li_rs10831496 Genome-wide association study of COVID-19 severity among the Chinese population Critical vs Controls CTSC (GRM5) ENSG00000168959 rs10831496 positive Severe Not available 1.77 7.17e-04
Li_rs10831496 Genome-wide association study of COVID-19 severity among the Chinese population Meta Analysis CTSC (GRM5) ENSG00000168959 rs10831496 positive Severe Not available 1.66 4.04e-08
Li_rs12329760 Genome-wide association study of COVID-19 severity among the Chinese population Meta-analysis (T allele) TMPRSS2 ENSG00000184012 rs12329760 negative Severe Not available 0.81 1.00e-02
Li_rs17000900 Genome-wide association study of COVID-19 severity among the Chinese population Meta Analysis MX1 ENSG00000157601 rs17000900 negative Severe Not available 0.73 5.00e-03
Li_rs1712779 Genome-wide association study of COVID-19 severity among the Chinese population critical vs controls NNMT, CADM1, ZBTB16, RBM1, REX02,C11orf71 (NXPE2) ENSG00000204361 rs1712779 negative Severe Not available 0.51 6.13e-04
Li_rs1712779 Genome-wide association study of COVID-19 severity among the Chinese population meta-analysis NNMT, CADM1, ZBTB16, RBM1, REX02,C11orf71 (NXPE2) ENSG00000204361 rs1712779 negative Severe Not available 0.49 1.38e-08
Li_rs2071430 Genome-wide association study of COVID-19 severity among the Chinese population meta-analysis MX1 ENSG00000157601 rs2071430 negative Severe Not available 0.65 3.80e-06
Li_rs2109069 Genome-wide association study of COVID-19 severity among the Chinese population severe vs control (Huoshenshan cohort) DPP9 ENSG00000142002 rs2109069 positive Severe Not available 1.33 3.20e-02
Li_rs2109070 Genome-wide association study of COVID-19 severity among the Chinese population combined meta-analysis DPP9 ENSG00000142002 rs2109070 positive Severe Not available 1.33 4.20e-03
Li_rs657152 Genome-wide association study of COVID-19 severity among the Chinese population combined metaanalysis ABO ENSG00000175164 rs657152 positive Severe Not available 1.27 1.70e-03
Lu_rs117665206 Genetic risk factors for death with SARS-CoV-2 from the UK Biobank COVID Death cases vs no death TMEM181 ENSG00000146433 rs117665206 Positive Critical Not available Not available Not available
Lu_rs138763430 Genetic risk factors for death with SARS-CoV-2 from the UK Biobank COVID Death cases vs no death BRF2 ENSG00000104221 rs138763430 Positive Critical Not available Not available Not available
Lu_rs147149459 Genetic risk factors for death with SARS-CoV-2 from the UK Biobank COVID Death cases vs no death ALOXE3 ENSG00000179148 rs147149459 Positive Critical Not available Not available Not available
Lu_rs150892504 Genetic risk factors for death with SARS-CoV-2 from the UK Biobank COVID Death cases vs no death ERAP2, ERAP1 ENSG00000164308 rs150892504 Positive Critical Not available Not available Not available
Medetalibeyoglu_rs18000450 Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection COVID-19 cases with homozygous rs1800450 mutation vs control MBL2 ENSG00000165471 rs1800450 positive Susceptibility Not available 12.1 1.00e-03
Medetalibeyoglu_rs18000450 Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection COVID-19 cases with homozygous mutation vs COVID-19 cases without mutation MBL2 ENSG00000165471 rs18000450 positive Severe Not available 5.3 1.00e-03
Medetalibeyoglu_rs18000450 Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection COVID-19 cases with heterozygous mutation vs COVID-19 cases without mutation MBL2 ENSG00000165471 rs1800450 positive Severe Not available 2.9 1.00e-03
Medetalibeyoglu_rs18000450 Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection COVID-19 cases with homozygous mutation vs COVID-19 cases without mutation MBL2 ENSG00000165471 rs1800450 positive Critical Not available 19.6 1.00e-03
Medetalibeyoglu_rs18000450 Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection COVID-19 cases with heterozygous mutation vs COVID-19 cases without mutation MBL2 ENSG00000165471 rs1800450 positive Critical Not available 6.9 1.00e-03
Monticelli_rs12329760 Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women Mild vs severe TMPRSS2 ENSG00000184012 rs12329760 Positive Mild 0.224393 0.7601 2.89e-02
Monticelli_rs12329760 Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women Young males TMPRSS2 ENSG00000184012 rs12329760 Positive Mild 0.224393 0.5804 2.00e-02
Monticelli_rs12329760 Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women Elderly women TMPRSS2 ENSG00000184012 rs12329760 Positive Mild 0.224393 0.5346 3.47e-02
Monticelli_rs12329760 Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women Young males with comorbidities TMPRSS2 ENSG00000184012 rs12329760 Positive Mild 0.224393 0.2969 5.70e-03
Monticelli_rs12329760 Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women Elderly women, comorbidities TMPRSS2 ENSG00000184012 rs12329760 Positive Mild 0.224393 0.4667 3.91e-02
Monticelli_rs2298659 Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women Mild vs severe TMPRSS2 ENSG00000184012 rs2298659 Positive Mild 0.206982 0.6947 3.90e-03
Namkoong_rs13050728 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan COVID-19 vs control IFNAR2 ENSG00000159110 rs13050728 Positive Susceptibility 0.573 1.1 1.50e-02
Namkoong_rs13050728 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young COVID-19 vs control IFNAR2 ENSG00000159110 rs13050728 Positive Susceptibility 0.58 1.16 2.40e-03
Namkoong_rs13050728 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young severe COVID-19 vs contr IFNAR2 ENSG00000159110 rs13050728 Positive Severe 0.605 1.28 3.90e-03
Namkoong_rs1886814 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan COVID-19 vs control FOXP4 ENSG00000137166 rs1886814 Positive Susceptibility 0.307 1.14 3.50e-03
Namkoong_rs1886814 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe COVID-19 vs control FOXP4 ENSG00000137166 rs1886814 Positive Severe 0.317 1.29 9.10e-05
Namkoong_rs1886814 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young COVID-19 vs control FOXP4 ENSG00000137166 rs1886814 Positive Susceptibility 0.314 1.17 4.50e-03
Namkoong_rs1886814 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young severe COVID-19 vs cntrl FOXP4 ENSG00000137166 rs1886814 Positive Severe 0.34 1.42 1.20e-04
Namkoong_rs210969 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe COVID-19 vs control DPP9 ENSG00000142002 rs210969 Positive Severe 0.133 1.2 3.10e-02
Namkoong_rs35081325 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe COVID-19 vs control LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 ENSG00000163818 rs35081325 Positive Severe 0.0032 7.06 9.00e-03
Namkoong_rs35081325 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young severe COVID-19 vs cntrl LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 ENSG00000163818 rs35081325 Positive Severe 0.003 11.8 1.40e-02
Namkoong_rs529565 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe COVID-19 vs control ABO ENSG00000175164 rs529565 Positive Severe 0.494 1.18 2.80e-03
Namkoong_rs529565 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young severe COVID-19 vs cntrl ABO ENSG00000175164 rs529565 Positive Severe 0.51 1.22 1.20e-02
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young Meta-severity vs Control DOCK2 ENSG00000134516 rs60200309 Positive Severe 0.159 2.0 2.00e-08
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Meta Japanese vs pan ancestry DOCK2 ENSG00000134516 rs60200309 unknown Severe Not available 1.97 1.20e-09
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan COVID-19 vs control DOCK2 ENSG00000134516 rs60200309 Positive Susceptibility 0.119 1.24 1.10e-03
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe vs non-severe COVID-19 DOCK2 ENSG00000134516 rs60200309 Positive Severe 0.08 1.27 2.80e-02
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe vs non-severe_young DOCK2 ENSG00000134516 rs60200309 Positive Severe 0.08 1.9 1.10e-05
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe COVID-19 vs control DOCK2 ENSG00000134516 rs60200309 Positive Severe 0.129 1.39 3.10e-04
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young COVID-19 vs control DOCK2 ENSG00000134516 rs60200309 Positive Susceptibility 0.123 1.32 5.10e-04
Namkoong_rs60200309 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young severe COVID-19 vs cntrl DOCK2 ENSG00000134516 rs60200309 Positive Severe 0.159 2.01 1.20e-08
Namkoong_rs72711165 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Young COVID-19 vs control TMEM65 ENSG00000164983 rs72711165 Positive Susceptibility 0.04 1.31 4.00e-02
Namkoong_rs77534576 Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan Severe COVID-19 vs control TAC4, KAT7,DLX3, FLJ45513 ENSG00000176358 rs77534576 Positive Severe 0.057 1.29 4.30e-02
Pairo-Castineira_rs10735079 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB OAS3,OAS2,OAS1 ENSG00000111331 rs10735079 Positive Critical Not available 1.3 1.60e-08
Pairo-Castineira_rs11085727 Genetic mechanisms of critical illness in Covid-19 hospitalised vs controls TYK2 ENSG00000105397 rs11085727 Positive Severe Not available 1.2 1.20e-13
Pairo-Castineira_rs13050728 Genetic mechanisms of critical illness in Covid-19 Hospitalised vs Controls IFNAR2 ENSG00000249624 rs13050728 Positive Severe Not available 1.2 5.10e-12
Pairo-Castineira_rs143334143 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB CCHCR1 ENSG00000204536 rs143334143 Positive Critical Not available 1.8 8.80e-18
Pairo-Castineira_rs143334143 Genetic mechanisms of critical illness in Covid-19 hospitalised vs controls CCHCR1 ENSG00000204536 rs143334143 Positive Severe Not available 1.3 1.50e-10
Pairo-Castineira_rs2109069 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB DPP9 ENSG00000142002 rs2109069 Positive Critical Not available 1.4 4.00e-12
Pairo-Castineira_rs2109069 Genetic mechanisms of critical illness in Covid-19 hospitalised vs controls DPP9 ENSG00000142002 rs2109069 Positive Severe Not available 1.2 7.00e-13
Pairo-Castineira_rs2236757 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB IFNAR2 ENSG00000249624 rs2236757 Negative Critical Not available 1.3 5.00e-08
Pairo-Castineira_rs3131294 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB NOTCH4 ENSG00000204301 rs3131294 Positive Critical Not available 1.5 2.80e-08
Pairo-Castineira_rs6489867 Genetic mechanisms of critical illness in Covid-19 hospitalised vs controls OAS1, OAS2, OAS3 ENSG00000089127 rs6489867 Negative Severe Not available 1.2 9.70e-10
Pairo-Castineira_rs71325088 Genetic mechanisms of critical illness in Covid-19 hospitalised vs controls LZTFL1, LOC107986083, SLC6A20, SACM1L, CCR9, FYCO1, XCR1, CCR1, CCR3 ENSG00000163818 rs71325088 Positive Severe Not available 1.9 2.50e-54
Pairo-Castineira_rs73064425 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB LZTFL1, FYCO1,CXCR6,CCR2,CCR3, SLC6A20 ENSG00000163818 rs73064425 Positive Critical Not available 2.1 4.80e-30
Pairo-Castineira_rs74956615 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB RAVER1, FDX2, ICAM1, ICAM4, ICAM5, ZGLP1, ICAM3, TYK2 ENSG00000161847 rs74956615 Positive Critical Not available 1.6 2.30e-08
Pairo-Castineira_rs9380142 Genetic mechanisms of critical illness in Covid-19 Critical COVID vs controls UKB HLA-G ENSG00000204632 rs9380142 Positive Critical Not available 1.3 3.20e-08
Pehlivan_rs1800450 Investigation of MBL2 and NOS3 functional gene variants in suspected COVID- 19 PCR (–) patients COVID-19 positive vs healthy controls MBL2 ENSG00000165471 rs1800450 negative Susceptibility Not available Not available 1.00e-03
Peloso_rs60870724 Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program COVID-19 positive meta-analysis vs population none none rs60870724 positive Susceptibility Not available 0.906 6.78e-14
Peloso_rs73062389 Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program COVID-19 positive meta-analysis vs population SLC6A20 ENSG00000163817 rs73062389 positive Susceptibility Not available 1.249 2.61e-17
Peloso_rs73910904 Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program COVID-19 positive hispanics vs not positive none- LINE L1MB7 none rs73910904 positive Susceptibility 0.02 1.705 3.78e-08
Peloso_rs8176719 Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program COVID-19 positive meta-analysis vs population ABO ENSG00000175164 rs8176719 positive Susceptibility Not available 1.109 4.10e-19
Roberts_rs111972040 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Male severity analysis SRRM1, NCMAP, CLIC4, RCAN3, NIPAL3, RUNX3 ENSG00000133226 rs111972040 Positive Severe 0.01 6.5 3.46e-03
Roberts_rs111972040 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Female severity analysis SRRM1, NCMAP, CLIC4, RCAN3, NIPAL3, RUNX3 ENSG00000133226 rs111972040 Positive Severe 0.01 9.37 8.01e-07
Roberts_rs111972040 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Meta Analysis SRRM1, NCMAP, CLIC4, RCAN3, NIPAL3, RUNX3 ENSG00000133226 rs111972040 Positive Severe 0.01 8.29 8.38e-09
Roberts_rs11385942 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Meta Analysis LZTFL1, SLC6A20, CCR9, FYCO1, CXCR6, XCR1, CCR2, CCR3 ENSG00000163817 rs11385942 Positive Severe 0.08 1.43 2.00e-02
Roberts_rs657152 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Meta Analysis ABO ENSG00000175164 rs657152 Positive Severe 0.36 1.26 2.20e-02
Roberts_rs6668622 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Male susceptibility analysis IVNS1ABP, SWT1, LOC107985239 ENSG00000116679 rs6668622 Positive Susceptibility 0.31 0.69 3.28e-09
Roberts_rs6668622 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Meta Analysis IVNS1ABP, SWT1, LOC107985239 ENSG00000116679 rs6668622 Positive Susceptibility 0.3 0.87 3.83e-05
Roberts_rs73166864 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Male susceptibility analysis immunoglobulin lambda locus, IGLL5, GNAZ, RSPH14, RAB36, BCR ENSG00000254709 rs73166864 Positive Susceptibility 0.03 1.97 1.19e-05
Roberts_rs73166864 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Female susceptibility analysis Immunoglobulin lamba locus (IGLL5), GNAZ,RSPH14,RAB36,BCR ENSG00000254709 rs73166864 Positive Susceptibility 0.02 1.55 2.21e-04
Roberts_rs73166864 AncestryDNA COVID-19 Host Genetic Study Identifies Three Novel Loci Meta Analysis Immunoglobulin lamba locus (IGLL5), GNAZ,RSPH14,RAB36,BCR ENSG00000254709 rs73166864 Positive Susceptibility 0.02 1.7 1.56e-08
Sayin_rs57875989 4R/5R Genotype Is There a Link between Circadian Clock Protein PERIOD 3 (PER3) (rs57875989) Variant and the Severity of COVID-19 Infection? COVID-19 survival vs mortality PER3 ENSG00000049246 rs57875989 positive Critical Not available Not available 7.00e-03
Sayin_rs57875989 4R/5R Genotype Is There a Link between Circadian Clock Protein PERIOD 3 (PER3) (rs57875989) Variant and the Severity of COVID-19 Infection? COVID-19 positive vs hospitali PER3 ENSG00000049246 rs57875989 positive Severe Not available Not available 3.40e-02
Shelton_rs13078854 Trans-ancestry analysis reveals genetic and non-genetic associations with COVID-19 susceptibility and severity COVID-19 severity vs controls LOC107986083, LZTFL1,SLC6A20, CCR9, FYCO1, CXCR6, XCR1 ENSG00000163818 rs13078854 Positive Severe Not available 2.0 1.60e-18
Shelton_rs9411378 Trans-ancestry analysis reveals genetic and non-genetic associations with COVID-19 susceptibility and severity COVID-19 positive vs COVID-19 ABO ENSG00000175164 rs9411378 Negative Susceptibility Not available 0.857 5.30e-20
Speletas_rs1800450 MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19 B-allele vs COVID-19 associated pnemonia MBL2 ENSG00000165471 rs1800450 positive Severe Not available 1.76 3.70e-02
Upadhyai_rs1006111 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases PPP2R1A ENSG00000105568 rs1006111 positive Severe Not available Not available 6.09e-04
Upadhyai_rs1042542 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases BIRC5 ENSG00000089685 rs1042542 positive Severe Not available Not available 4.41e-04
Upadhyai_rs12649400 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases MAPK10 ENSG00000109339 rs12649400 positive Severe Not available Not available 6.49e-04
Upadhyai_rs13334749 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases PPL ENSG00000118898 rs13334749 positive Severe Not available Not available 7.45e-04
Upadhyai_rs155788 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases SQSTM1 ENSG00000161011 rs155788 positive Severe Not available Not available 6.47e-04
Upadhyai_rs17142392 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases LY86 ENSG00000112799 rs17142392 positive Severe Not available Not available 8.22e-04
Upadhyai_rs2923084 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases CAND1.11 100130460 rs2923084 positive Severe Not available Not available 1.58e-05
Upadhyai_rs2957702 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases CAND1.11 100130460 rs2957702 positive Severe Not available Not available 6.27e-04
Upadhyai_rs2957707 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases CAND1.11 100130460 rs2957707 positive Severe Not available Not available 3.12e-04
Upadhyai_rs2957714 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases CAND1.11 100130460 rs2957714 positive Severe Not available Not available 2.95e-04
Upadhyai_rs360102 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases TMEM63A ENSG00000196187 rs360102 positive Severe Not available Not available 7.97e-04
Upadhyai_rs3766539 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases CHIT1 ENSG00000133063 rs3766539 positive Severe Not available Not available 1.87e-04
Upadhyai_rs4800182 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases OSBPL1A ENSG00000141447 rs4800182 positive Severe Not available Not available 9.21e-04
Upadhyai_rs6490100 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases FBXW8 ENSG00000174989 rs6490100 positive Severe Not available Not available 1.06e-04
Upadhyai_rs7305574 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases CRACR2A ENSG00000130038 rs7305574 positive Severe Not available Not available 6.09e-04
Upadhyai_rs7318817 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases FLT3 ENSG00000122025 rs7318817 positive Severe Not available Not available 6.54e-04
Upadhyai_rs7327609 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases FLT3 ENSG00000122025 rs7327609 positive Severe Not available Not available 6.44e-04
Upadhyai_rs9427097 Genomic and Ancestral Variation Underlies the Severity of COVID-19 Clinical Manifestation in Individuals of European Descent Asymptomatic vs Severe cases ADAR ENSG00000160710 rs9427097 positive Severe Not available Not available 3.08e-04
van der Made_12905756_12905759del Presence of Genetic Variants Among Young Men With Severe COVID-19 Severe COVID-19 TLR7 ENSG00000196664 - Positive Severe Not available Not available Not available
van Moorsel_rs35705950 The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population COVID cases vs control discov MUC5B ENSG00000117983 rs35705950 negative Severe 0.04 0.42 2.30e-02
van Moorsel_rs35705950 The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population COVID-19 cases vs controls UKB MUC5B ENSG00000117983 rs35705950 negative Severe 0.08 0.66 1.00e-03
van Moorsel_rs35705950 The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population Severe COVID vs controls Coh1 MUC5B ENSG00000117983 rs35705950 negative Severe 0.1 0.81 3.90e-02
van Moorsel_rs35705950 The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population Severe COVID vs controls Coh2 MUC5B ENSG00000117983 rs35705950 negative Severe 0.1 0.79 3.00e-02
van Moorsel_rs35705950 The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population Meta Analysis MUC5B ENSG00000117983 rs35705950 negative Severe Not available 0.75 6.63e-06
van_Blokland_rs11844522 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 IGH HGNC:5477 rs11844522 Positive Mild Not available Not available 1.90e-07
van_Blokland_rs11844522 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 vs B2 IGH HGNC:5477 rs11844522 Positive Severe Not available Not available 3.98e-02
van_Blokland_rs13288295 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 vs C1 DAB2IP, TTLL11 ENSG00000136848 rs13288295 Positive Mild Not available Not available 3.40e-02
van_Blokland_rs143825287 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 vs C2 LOC102723831, MIR12131, MTHFD1L, AKAP12 HGCN:32970 rs143825287 Positive Mild Not available Not available 2.42e-02
van_Blokland_rs143825287 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 vs C1 LOC102723831, MIR12131, MTHFD1L, AKAP12 102723831 rs143825287 Positive Mild Not available Not available 3.10e-02
van_Blokland_rs5798227 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 KRT126P, LOC400036 HGNC 32970 rs5798227 Positive Mild Not available Not available 2.20e-07
van_Blokland_rs75517918 Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility D1 vs C2 ZFYVE28 ENSG00000159733 rs75517918 Positive Mild Not available Not available 3.41e-02
Wang_novel Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility COVID-19 patients vs control n MUC12 ENSG00000205277 Novel_Wang positive Susceptibility Not available 18.0 4.70e-17
Wang_rs200584390 Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility COVID-19 patients vs control n RIMBP3 ENSG00000275793 rs200584390 positive Susceptibility Not available 9.29 1.50e-13
Wang_rs200975425 Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility COVID-19 patients vs control n GOLGA8B ENSG00000215252 rs200975425 negative Susceptibility Not available 5.4 9.40e-10
Wang_rs6020298 Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility mild vs severe cases TMEM189, UBE2V1 ENSG00000124208 rs6020298 positive Severe Not available 1.2 4.10e-06
Wulandari_rs12329760 Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients Severity with SNP vs morbidity TMPRSS2 ENSG00000184012 rs12329760 positive Morbidity Not available Not available 4.20e-02
Zhang_ rs181939581 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IFNAR1 ENSG00000142166 rs181939581 Positive Critical Not available Not available Not available
Zhang_rs114566317 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls TICAM1 ENSG00000127666 rs114566317 Positive Critical Not available Not available Not available
Zhang_rs121434431 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID-19 vs control TLR3 ENSG00000164342 rs121434431 Positive Critical Not available Not available Not available
Zhang_rs199550479 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IRF3 ENSG00000126456 rs199550479 Positive Critical Not available Not available Not available
Zhang_rs201782115 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls TICAM1 ENSG00000127666 rs201782115 Positive Critical Not available Not available Not available
Zhang_rs72552343 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IFNAR1 ENSG00000142166 rs72552343 Positive Critical Not available Not available Not available
Zhang_rs746291558 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IFNAR1 ENSG00000142166 rs746291558 Positive Critical Not available Not available Not available
Zhang_rs753582183 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IRF7 ENSG00000185507 rs753582183 Positive Critical Not available Not available Not available
Zhang_rs756347258 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IRF7 ENSG00000185507 rs756347258 Positive Critical Not available Not available Not available
Zhang_rs765147452 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IRF7 ENSG00000185507 rs765147452 Positive Critical Not available Not available Not available
Zhang_rs970393690 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Critical COVID vs controls IRF7 ENSG00000185507 rs970393690 Positive Critical Not available Not available Not available
Zhu_rs11032789 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Severe vs Apo A levels EHF ENSG00000135373 rs11032789 positive Severe 0.04 Not available 6.40e-10
Zhu_rs1801020 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Severe vs APTT (activated partial thromboplastin time) levels F12/SLC34A1 ENSG00000131187 rs1801020 positive Severe 0.254 Not available 4.13e-16
Zhu_rs28946889 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Severity vs Total Bilirubin level UGT1A complex ENSG00000241635 rs28946889 positive Severe 0.4 Not available 5.08e-14
Zhu_rs28946889 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Severity vs Total Bilirubin level UGT1A complex ENSG00000241635 rs28946889 positive Severe 0.4 Not available 1.51e-16
Zhu_rs56393506 A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity Severity vs Lipoprotein A LPA ENSG00000198670 rs56393506 positive Severe 0.114 Not available 1.97e-14